#breast cancer — Monday, July 27, 2026 (2 items)
| 0 | ℹ |
ALFAssay: A feed‑forward neural network for quantitative fragmentomics‑based ctDNA profiling in breast cancer.
(journals.plos.org)
|
PLOS Computational Biology 2026-07-27 | #ctdna #breast cancer #machine learning #fragmentomics #liquid biopsy | |
| 0 | ℹ |
Single-fraction or multi-fraction stereotactic ablative body radiotherapy followed by atezolizumab in advanced triple-negative breast cancer: a randomized phase II trial.
(nature.com)
|
Nature Communications 2026-07-27 | #immunotherapy #breast cancer #radiotherapy #clinical trial #checkpoint_inhibition |